BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7522396)

  • 1. Improvement of sickle cell anemia by iron-limited erythropoiesis.
    Castro O; Poillon WN; Finke H; Massac E
    Am J Hematol; 1994 Oct; 47(2):74-81. PubMed ID: 7522396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular hemoglobin S polymerization and the clinical severity of sickle cell anemia.
    Poillon WN; Kim BC; Castro O
    Blood; 1998 Mar; 91(5):1777-83. PubMed ID: 9473246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron in sickle cell disease: a review why less is better.
    Koduri PR
    Am J Hematol; 2003 May; 73(1):59-63. PubMed ID: 12701123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease.
    Brown AK; Sleeper LA; Miller ST; Pegelow CH; Gill FM; Waclawiw MA
    Arch Pediatr Adolesc Med; 1994 Aug; 148(8):796-804. PubMed ID: 7519102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of manual chronic partial exchange transfusion in children with sickle disease.
    Aloni MN; Lê PQ; Heijmans C; Huybrechts S; Devalck C; Azzi N; Ngalula-Mujinga M; Ferster A
    Hematology; 2015 Jun; 20(5):284-8. PubMed ID: 25133935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of recreational scuba diving on erythropoiesis-"normobaric oxygen paradox" or "plasma volume regulation" as a trigger for erythropoietin?
    Perović A; Žarak M; Njire Bratičević M; Dumić J
    Eur J Appl Physiol; 2020 Jul; 120(7):1689-1697. PubMed ID: 32488585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients.
    Chang J; Bird R; Clague A; Carter A
    Pathology; 2007 Jun; 39(3):349-53. PubMed ID: 17558864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia.
    Ballas SK; Marcolina MJ
    Transfusion; 2006 Jan; 46(1):105-10. PubMed ID: 16398738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial evaluation of iron stores in pregnant Nigerians with hemoglobin SS or SC.
    Abudu OO; Macaulay K; Oluboyede OA
    J Natl Med Assoc; 1990 Jan; 82(1):41-8. PubMed ID: 2304096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoiesis activity, iron availability and reticulocyte hemoglobinization during treatment with hemodialysis and in subjects with uremia.
    Schoorl M; Schoorl M; Nubé MJ; Bartels PC
    Clin Lab; 2006; 52(11-12):621-9. PubMed ID: 17175894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacological manipulation of fetal haemoglobin: trials using hydroxyurea and recombinant human erythropoietin.
    el-Hazmi MA; al-Momen A; Warsy AS; Kandaswamy S; Huraib S; Harakati M; al-Mohareb F
    Acta Haematol; 1995; 93(2-4):57-61. PubMed ID: 7543719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of sickle cell crises with multiple phlebotomies].
    Bouchaïr N; Manigne P; Kanfer A; Raphalen P; de Montalembert M; Hagege I; Verschuur A; Maier-Redelsperger M; Girot R
    Arch Pediatr; 2000 Mar; 7(3):249-55. PubMed ID: 10761600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The haematology of steady state homozygous sickle cell disease: interrelationships between haematological indices.
    Maude GH; Hayes RJ; Serjeant GR
    Br J Haematol; 1987 Aug; 66(4):549-58. PubMed ID: 2444245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overt iron deficiency in sickle cell disease.
    Haddy TB; Castro O
    Arch Intern Med; 1982 Sep; 142(9):1621-4. PubMed ID: 7114979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular effects of hydroxyurea in Hb SC disease.
    Steinberg MH; Nagel RL; Brugnara C
    Br J Haematol; 1997 Sep; 98(4):838-44. PubMed ID: 9326175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle cell anemia with few painful crises is characterized by decreased red cell deformability and increased number of dense cells.
    Ballas SK
    Am J Hematol; 1991 Feb; 36(2):122-30. PubMed ID: 1707225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of derived Coulter red blood cell parameters for the assessment of iron deficiency in adults with congenital heart disease.
    Dopsaj V; Mikovic-Golubovic G; Martinovic J; Kalimanovska-Ostric D
    Int J Lab Hematol; 2012 Oct; 34(5):461-72. PubMed ID: 22452801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reticulocyte hemoglobin content (MCHr) in the detection of iron deficiency.
    Urrechaga Igartua E; Hoffmann JJML; Izquierdo-Álvarez S; Escanero JF
    J Trace Elem Med Biol; 2017 Sep; 43():29-32. PubMed ID: 27836440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyurea and erythropoietin therapy in sickle cell anemia.
    Goldberg MA; Brugnara C; Dover GJ; Schapira L; Lacroix L; Bunn HF
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):74-81. PubMed ID: 1379376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.